BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leoni MC, Ustianowski A, Farooq H, Arends JE. HIV, HCV and HBV: A Review of Parallels and Differences. Infect Dis Ther 2018;7:407-19. [PMID: 30182282 DOI: 10.1007/s40121-018-0210-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Wang S, Tan Y, Huang J, Yang X, Li S. Nanoparticle-Based Lateral Flow Biosensors Integrated With Loop-Mediated Isothermal Amplification for the Rapid and Visual Diagnosis of Hepatitis B Virus in Clinical Application. Front Bioeng Biotechnol 2021;9:731415. [PMID: 34595159 DOI: 10.3389/fbioe.2021.731415] [Reference Citation Analysis]
2 Cabral LKD, Grisetti L, Pratama MY, Tiribelli C, Pascut D. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers (Basel) 2022;14:2700. [PMID: 35681679 DOI: 10.3390/cancers14112700] [Reference Citation Analysis]
3 Michel Wolf J, Zingalli Bueno Pereira VR, Zanetti Ballardin Roncato PA, Castagna Wortmann A, Stumm GZ, Oliveira da Silva F, Lunge VR, Simon D. The HLA-G 14-bp insertion/deletion polymorphism is associated with chronic hepatitis B in Southern Brazil: A case-control study. Hum Immunol 2020;81:79-84. [PMID: 31955869 DOI: 10.1016/j.humimm.2020.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Philips CA, Ahamed R, Abduljaleel JK, Rajesh S, Augustine P. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021;13:e19152. [PMID: 34733599 DOI: 10.7759/cureus.19152] [Reference Citation Analysis]
5 Chen X, Zhou Q, Dong S, Wang S, Liu R, Wu X, Li S. Multiple Cross Displacement Amplification Linked with Nanoparticles-Based Lateral Flow Biosensor in Screening of Hepatitis B Virus in Clinical Application. Infect Drug Resist 2021;14:1219-29. [PMID: 33790592 DOI: 10.2147/IDR.S297645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pastuch-Gawołek G, Gillner D, Król E, Walczak K, Wandzik I. Selected nucleos(t)ide-based prescribed drugs and their multi-target activity. Eur J Pharmacol 2019;865:172747. [PMID: 31634460 DOI: 10.1016/j.ejphar.2019.172747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
7 Ivanics T, Rizzari M, Moonka D, Al-Kurd A, Delvecchio K, Kitajima T, Elsabbagh AM, Collins K, Yoshida A, Abouljoud M, Nagai S. Retransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction. Am J Transplant 2021;21:1100-12. [PMID: 32794649 DOI: 10.1111/ajt.16254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lücke J, Sabihi M, Zhang T, Bauditz LF, Shiri AM, Giannou AD, Huber S. The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies. Semin Immunopathol 2021. [PMID: 33851257 DOI: 10.1007/s00281-021-00854-z] [Reference Citation Analysis]
9 Asadi-Pooya AA, Bartolini L. Prevention and treatment of temporal lobe epilepsy: lessons from hepatitis B story! Int J Neurosci 2020;130:1151-5. [PMID: 32053411 DOI: 10.1080/00207454.2020.1730370] [Reference Citation Analysis]